fenofibric acid has been researched along with Complications of Diabetes Mellitus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adeghate, E; Kalasz, H; Teke, K; Veress, G | 1 |
Guo, W; Hernández, C; Roy, S; Simó, R; Trudeau, K; Villarroel, M | 1 |
Häring, HU; Mehnert, H; Renner, R; Schleicher, E | 1 |
1 review(s) available for fenofibric acid and Complications of Diabetes Mellitus
Article | Year |
---|---|
Medicinal chemistry of drugs used in diabetic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus; Endothelin-1; Fenofibrate; Humans; Hypoglycemic Agents; Peroxisome Proliferator-Activated Receptors; Receptors, Angiotensin | 2010 |
2 other study(ies) available for fenofibric acid and Complications of Diabetes Mellitus
Article | Year |
---|---|
Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.
Topics: Anticholesteremic Agents; Blotting, Western; Capillary Permeability; Cells, Cultured; Claudin-1; Collagen Type IV; Dextrans; Diabetes Complications; Dose-Response Relationship, Drug; Fenofibrate; Fibronectins; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Glucose; Humans; Interleukin-1beta; Membrane Proteins; Microscopy, Confocal; Phosphoproteins; Retinal Pigment Epithelium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Up-Regulation; Zonula Occludens-1 Protein | 2011 |
[The effect of fenofibrate on the lipid level in diabetic patients].
Topics: Aged; Diabetes Complications; Female; Fenofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Propionates | 1983 |